CDE: [OMFS Lecture Series] Principles of Parotid Surgery

Dec, 2019
05:30 PM-07:30 PM

Perelman Center for Advanced Medicine
Conference Room 14-101 South

Time: 5:30 – 7:00 pm | Light dinner will be provided
Cost: Free; Registration is required for CE credit. Email or call 215.827.9476
CE Credits: 1.5 lecture credits


Review the contemporary techniques for the surgical management of benign and malignant neoplasms of the parotid gland. The performance of the time honored superficial parotidectomy, commonly performed partial superficial parotidectomy, and poorly understood extracapsular dissection will be discussed and illustrated in the context of benign and malignant neoplastic disease. The indications for elective neck dissections for N0 disease associated with malignant parotid tumors will be outlined with a curative intent approach. Finally, surgical access to the deep lobe will be explained utilizing a novel approach.

Educational Objectives

  • Distinguish the techniques of the superficial parotidectomy, the partial superficial parotidectomy, and the extracapsular dissection for management of benign and malignant parotid tumors.
  • Explain the inevitable performance of the extracapsular dissection in many superficial parotidectomies and partial superficial parotidectomies.
  • Provide a rationale for the performance of a fine needle aspiration biopsy prior to parotid surgery.
  • Enumerate the indications for neck dissection when managing the N0 neck associated with a malignant tumor of the parotid gland.


Eric R. Carlson, DMD, MD, EdM, FACS
University of Tennessee Graduate School of Medicine
Professor and Kelly L. Krahwinkel Chairman, OMFS Department
Director of Oral and Maxillofacial Surgery Residency Program
Director, Oral/Head and Neck Oncologic Surgery Fellowship

Dr. Carlson’s clinical focus is on benign and malignant tumors of the oral cavity, head, and neck, salivary gland surgery, and reconstructive surgery.

His translational research initiatives focus on the identification of human papillomavirus (HPV) in oral and oropharyngeal cancer and the preoperative staging of head and neck cancer with positron emission tomography/computed tomography (PET/CT) and a variety of tracers. The ability to detect a specific carcinogen and proper staging of these cancers is of important prognostic value.

University of Pennsylvania School of Dental Medicine is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

University of Pennsylvania School of Dental Medicine designates this activity for 1.5 continuing education credits.